Dieta Health used AI to monitor stool characteristics in hospitalized patients with severe ulcerative colitis in a clinical trial at Cedars-Sinai. The study, published in Crohn’s & Colitis 360, found statistically significant correlations between stool characteristics and blood CRP.
Dieta Health, a digital health startup building gastroenterology AI, announced results from two studies presented at the 2023 Digestive Disease Week (DDW) Conference.
Los Angeles, CA - August 19th, 2021: Dieta Health announced a $1.2M pre-seed funding round led by Tom Williams of Heron Rock Fund with participation from Techstars Ventures (follow-on), Cedars-Sinai, and Verissimo Ventures. The group of investors backing Dieta include the largest healthcare payer,
Dieta has developed computer vision technology that turns stool images into clinical data. The page says bowel movements have traditionally been measured subjectively using the Bristol Scale.
